Regular Article
Biochemical Characterization of the Human Liver Cytochrome P450 Arachidonic Acid Epoxygenase Pathway

https://doi.org/10.1006/abbi.1996.0229Get rights and content

Abstract

Human liver microsomal fractions metabolized arachidonic acid in the presence of NADPH yielding epoxyeicosatrienoic acids and their hydration products, dihydroxyeicosatrienoic acids, as the principal reaction products. Inhibition studies using polyclonal antibodies prepared against recombinant CYP2C8, an abundant human liver cytochrome P450 epoxygenase, demonstrated 85–90% inhibition of arachidonic acid epoxide formation. Both epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids were detected in large amounts in human liver using gas chromatography/mass spectrometry. Chiral analysis of the endogenous liver epoxides demonstrated a preference for the 14(R),15(S)-, 11(R),12(S)-, and 8(S),9(R)-epoxyeicosatrienoic acid enantiomers. Importantly, the chirality of liver epoxyeicosatrienoic acids matched that previously reported for recombinant CYP2C8 (Zeldinet al.(1995)Arch. Biochem. Biophys.322, 76–86). Incubations of both human liver cytosolic and microsomal fractions with synthetic epoxyeicosatrienoic acids revealed a 10-fold higher rate of dihydroxyeicosatrienoic acid formation with cytosolic relative to microsomal fractions. Recombinant human liver cytosolic epoxide hydrolase rapidly and regioselectively hydrated epoxyeicosatrienoic acids. We conclude, based on these data, that CYP2C8 is one of the primary, constitutive hepatic arachidonic acid epoxygenases responsible for formation of epoxyeicosatrienoic acids and that cytosolic epoxide hydrolase is the principal liver enzyme which forms the dihydroxyeicosatrienoic acids. We speculate that these biologically active eicosanoids may be important in maintaining homeostasis in the liver.

References (0)

Cited by (129)

  • Prediction of inter-individual variability on the pharmacokinetics of CYP2C8 substrates in human

    2017, Drug Metabolism and Pharmacokinetics
    Citation Excerpt :

    CYP2C8 is a major hepatic CYP enzyme that accounts for approximately 7% of total CYPs in human liver [1]. CYP2C8 plays an important role in the hepatic metabolism of over 100 drugs, such as antidiabetic [2], anticancer [3], and antimalarial drugs [4], as well as endogenous and natural compounds, such as steroids [5], carotenoids [6], and arachidonic acid [7]. The expression of CYP2C8 protein in human liver microsomes was reported to have an inter-individual CV of 86.7% [8].

  • Risk factors for post-transplant diabetes mellitus in renal transplant: Role of genetic variability in the CYP450-mediated arachidonic acid metabolism

    2016, Molecular and Cellular Endocrinology
    Citation Excerpt :

    The epoxygenase branch of this pathway leads to the synthesis of epoxyeicosatrienoic acids (EETs), which have vasodilator, profibrinolytic and anti-inflammatory properties (Yang et al., 2015; Imig, 2005; Node et al., 1999). CYP2C9 and, most importantly, CYP2C8 and CYP2J2 are mostly responsible for this synthesis (Alkayed et al., 2002; Wu et al., 1997; Zeldin, 2001; Zeldin et al., 1996). In a parallel hydroxylase route, AA is also metabolized by CYP4A11 and CYP4F2 to 20-hidroxyeicosatetraenoic acid (20-HETE) (Lasker et al., 2000), which may increase blood pressure by vasoconstriction or, paradoxically, promote antihypertension by increasing sodium excretion in the kidney (Miyata and Roman, 2005; Hoopes et al., 2015).

  • Endocannabinoid metabolism by cytochrome P450 monooxygenases

    2015, Prostaglandins and Other Lipid Mediators
    Citation Excerpt :

    However, the propensity to form these various regio- and stereoisomers is not the same among all CYP isoforms. For instance, CYP2C8 produces only the 14,15- and 11,12-EETs in appreciable quantities [108–109] and 2C9 only produces 14,15-; 11,12-; and 8,9-EET [109]. The CYP4 family, which includes CYP4A11, CYP4A22, and CYP4F isoforms, predominantly produce 20-HETE [88,110].

View all citing articles on Scopus
1

To whom correspondence should be addressed at Laboratory of Pulmonary Pathobiology, National Institutes of Health, National Institute of Environmental Health Sciences, P.O. Box 12233, Research Triangle Park, NC 27709. Fax: (919) 541-4133. E-mail: zeldin@niehs. nih.gov.

View full text